Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
Selma Turkovic, PBM Practitioner at NHS Blood and Transplant, shared a post on LinkedIn:
“Blood Transfusion Education and Discussion Group (BTEDG) webinar 61
Topic: We matched it. We cross‑matched it. They still haemolysed. Unpacking DHTR in Sickle Cell patients.
Can you tell the difference between Delayed Haemolytic Transfusion Reaction (DHTR) and Hyperhaemolysis Syndrome?
Did you know that 56% of DHTRs are missed?
Do you know which laboratory tests are key to confirming and monitoring a DHTR?
Join us to explore these important questions and learn how to recognise and manage this serious transfusion complication.
Wednesday 29th April 2026
14:00–15:00 (UK time)
Microsoft Teams Webinar
Speaker: Daniel Monteiro
Principal Biomedical Scientist, Specialist Red Cell Centre (Synnovis Hub)
Scientific Advisor, NHS Sickle and Thalassaemia Screening Programme
An essential session for anyone involved in transfusion, haemoglobinopathy care, and laboratory haematology.
Please share within your teams and networks.”
More posts featuring Selma Turkovic on Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?